| For: | Schinas G, Polyzou E, Dimakopoulou V, Tsoupra S, Gogos C, Akinosoglou K. Immune-mediated liver injury following COVID-19 vaccination. World J Virol 2023; 12(2): 100-108 [PMID: 37033146 DOI: 10.5501/wjv.v12.i2.100] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3249/full/v12/i2/100.htm |
| Number | Citing Articles |
| 1 |
VV Reshetnikov, GS Shepelkova, AV Rybakova, AP Trashkov, VV Yeremeev, RA Ivanov. The candidate anti-tuberculosis mRNA vaccine immunogenicity and reactogenicity dependency on the animal’s sex and the vaccine dose. Bulletin of Russian State Medical University 2024; (2024(5)) doi: 10.24075/brsmu.2024.045
|
| 2 |
Meirong Wang, Juan Qi, Yujuan Liu. Autoimmune hepatitis following COVID-19 vaccination: Clinical characteristics of 35 reported cases. Drug Discoveries & Therapeutics 2023; 17(3) doi: 10.5582/ddt.2023.01022
|
| 3 |
M.E. Zharova, I.O. Ivanikov, Yu.V. Grigorieva, E.L. Nikonov. Liver injury in COVID-19: clinical features and risk factors. Russian Journal of Evidence-Based Gastroenterology 2023; 12(3) doi: 10.17116/dokgastro20231203151
|
| 4 |
Yunxuan Feng, Wanbo Tai, Pei Huang, Shaolong Qi, Xinyang Yu, Mengfei Li, Mengyao Li, Miya Zhang, Fangfang Cao, Xiaomin Gao, Kai Yang, Bing Bai, Jiaqi Lei, Meiqi Cheng, Yongcan Li, Gong Cheng, Xiaoyuan Chen, Guocan Yu. Albumin-recruiting lipid nanoparticle potentiates the safety and efficacy of mRNA vaccines by avoiding liver accumulation. Nature Materials 2025; 24(11) doi: 10.1038/s41563-025-02284-w
|
| 5 |
Alfonso Rodriguez-Espada, Moises Salgado-de la Mora, Briana Mariette Rodriguez-Paniagua, Nathaly Limon-de la Rosa, Monica Itzel Martinez-Gutierrez, Santiago Pastrana-Brandes, Nalu Navarro-Alvarez. Histopathological impact of SARS-CoV-2 on the liver: Cellular damage and long-term complications. World Journal of Gastroenterology 2024; 30(22): 2866-2880 doi: 10.3748/wjg.v30.i22.2866
|
| 6 |
Batuhan Erdoğdu, Ozan Kaplan, Mustafa Çelebier, Ümit Yavuz Malkan, İbrahim Celalettin Haznedaroğlu. Hepatic Metabolic Dysregulation as a Potential Amplifier of Leukemogenesis Following mRNA Vaccination: A Novel Mechanistic Hypothesis. Medicina 2025; 61(9) doi: 10.3390/medicina61091687
|
| 7 |
Mehajabin Tusquin Khan, Parveen Sultana, Md Intekhab Rahman, Tanzila Subrina Rahman, Nahid Farzana Chowdhury. Changes of Liver Function Tests Among COVID-19 Vaccinated People at IBMCHR. Islami Bank Medical College Journal 2026; 21(2) doi: 10.70945/ibmcj.v21i02.0175
|
| 8 |
János Szebeni, Akos Koller. Multisystem Endothelial Inflammation: A Key Driver of Adverse Events Following mRNA-Containing COVID-19 Vaccines. Vaccines 2025; 13(8) doi: 10.3390/vaccines13080855
|
| 9 |
Botond Z. Igyártó, Zhen Qin. The mRNA-LNP vaccines – the good, the bad and the ugly?. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1336906
|
| 10 |
Berna İmge Aydoğan, Uğur Ünlütürk, Mustafa Cesur. Diagnosis of latent autoimmune diabetes after SARS–Cov2 vaccination in adult patients previously diagnosed with type 2 diabetes mellitus. International Journal of Diabetes in Developing Countries 2024; 44(3) doi: 10.1007/s13410-023-01261-w
|
| 11 |
Nipuni Maniyamgama, Ki Hyun Bae, Jialing Lee, James Hoi Po Hui, Yi Yan Yang. Enhanced mRNA and pDNA delivery via PEGylated solid lipid nanoparticles with an optimally balanced ionizable/cationic lipid content. Journal of Materials Chemistry B 2025; 13(38) doi: 10.1039/D5TB00470E
|
| 12 |
Kai Zhu, Olivia Tsai, Daljeet Chahal, Trana Hussaini, Eric M. Yoshida. COVID-19 and Liver Disease: An Evolving Landscape. Seminars in Liver Disease 2023; 43(03) doi: 10.1055/a-2157-3318
|
| 13 |
Francesca Granata, Simona Leoni, Valeria Di Stefano, Anna Ludovica Fracanzani, Giovanna Graziadei. Recurrent hepatic flares after SARS-CoV-2 vaccination in a patient with erythropoietic protoporphyria: A case report. Rare 2025; 3 doi: 10.1016/j.rare.2025.100097
|
| 14 |
Ayaka Tanifuji, Satoko Ohfuji, Kosuke Matsumoto, Masanori Abe, Atsumasa Komori, Atsushi Takahashi, Kazuhito Kawata, Ken Sato, Satoru Joshita, Takeji Umemura, Masayuki Ueno, Nobuaki Nakayama, Keisuke Kakisaka, Teruko Arinaga‐Hino, Koichi Ito, Sachiko Kanai, Ryo Miura, Toshihiko Arizumi, Yoshinari Asaoka, Takanori Ito, Tetsuya Shimizu, Hiroshi Yoshida, Masayuki Ohta, Suguru Mizuno, Hiroyuki Isayama, Youichi Morimoto, Satoshi Mochida, Hiromasa Ohira, Atsushi Tanaka. Safety and effectiveness of SARS‐CoV‐2 vaccines for patients with intractable hepatobiliary diseases: A multicenter, questionnaire‐based, cross‐sectional study. Hepatology Research 2024; 54(7) doi: 10.1111/hepr.14018
|